ALST.US Allstar Health Brands Inc
- Market cap
- USD 140K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ALST.US undervalued?
Graham numberThe Graham number of Allstar Health Brands Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Allstar Health Brands Inc fundamental analysis
No fundamental analysis for Allstar Health Brands Inc yet.
Allstar Health Brands Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Allstar Health Brands Inc
Allstar Health Brands, Inc. engages in the sales and distribution of pharmaceutical OTC products. It is also involved in licensing of pharmaceutical OTC and nutraceutical markets. Allstar Health Brands, Inc. was formerly known as Axxess Pharma, Inc. and changed its name to Allstar Health Brands, Inc. in June 2017. The company is based in Georgetown, Canada.
Full company profileAllstar Health Brands Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Allstar Health Brands Inc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 33.9K | 34.0K | 3.78K | - | 250K | 19.9K | 92.00 | - | - | - | - |
| Gross Profit | -79.2K | 13.1K | 3.78K | - | 61.5K | 16.4K | 92.00 | - | - | - | - |
| Operating Income | -479K | -771K | -69.6K | -224K | -241K | -212K | -189K | -216K | -324K | -199K | -356K |
| EBITDA | -479K | -771K | -69.6K | -224K | -3.45M | -901K | -121K | -73.9K | -324K | -199K | -356K |
| Net Income | -7.09M | -5.49M | -543K | -509K | -3.87M | -1.52M | -606K | -499K | -1.43M | -749K | -1.00M |
| EPS | -7,968,493 | -19,322 | -37 | -5.14 | -0.82 | -0.06 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 15.5K | 1.14K | 25.00 | - | 24.5K | 1.91K | 1.62K | 220.00 | 189.00 | 1.48K | 91.1K |
| Total Liabilities | 10.8M | 11.8M | 11.4M | 9.53M | 8.51M | 8.85M | 8.84M | 9.30M | 10.7M | 11.5M | 12.3M |
| Shareholders' Equity | -10.7M | -11.8M | -11.4M | -9.53M | -8.49M | -8.85M | -8.83M | -9.30M | -10.7M | -11.5M | -12.2M |
| Cash & Short-term Investments | 195.00 | 1.14K | 25.00 | - | - | 424.00 | 133.00 | 220.00 | 189.00 | 1.48K | 1.15K |
| Total Debt | 2.58M | 3.18M | 2.89M | 2.69M | 1.90M | 2.00M | 2.22M | 2.21M | 2.78M | 2.96M | 2.96M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -60.6K | -22.5K | -1.12K | -108K | -689K | -257K | -241K | -50.9K | -474K | - | -538K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 | 0.00 | 4.00 | 1.00 | 1.00 | - | 14.00 |
| Free Cash Flow | -60.6K | -22.5K | -1.12K | -108K | -689K | -257K | -241K | -50.9K | -474K | - | -538K |
| Ratios | |||||||||||
| ROA | -45,663.2% | -481,360.7% | -2,170,308.0% | - | -15,793.6% | -79,590.2% | -37,474.6% | -226,974.1% | -754,868.3% | -50,525.8% | -1,100.9% |
| Net Profit Margin | -20,940.6% | -16,152.6% | -14,353.9% | - | -1,547.8% | -7,630.2% | -658,250.0% | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Allstar Health Brands Inc dividends
Allstar Health Brands Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:40000 on Dec 23, 2019.
Who owns Allstar Health Brands Inc
- Insiders 0.00%
- Institutions 2.03%
- Public & others 97.97%
- Shares outstanding 350M
Allstar Health Brands Inc company profile
- Company name
- Allstar Health Brands Inc
- Ticker
- ALST.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Fiscal year end
- December
- Address
- 44 Greystone Crescent, Georgetown, ON, Canada, L7G1G9
- Phone
- 416-410-6006
- Website
- allstarhealthbrands.com
About Allstar Health Brands Inc
Allstar Health Brands, Inc. engages in the sales and distribution of pharmaceutical OTC products. It is also involved in licensing of pharmaceutical OTC and nutraceutical markets. Allstar Health Brands, Inc. was formerly known as Axxess Pharma, Inc. and changed its name to Allstar Health Brands, Inc. in June 2017. The company is based in Georgetown, Canada.
Allstar Health Brands Inc management
2- Dr. Peter Daniel Bagi M.D.President, Treasurer & Director · born 1953
- Mr. Neil MellorSenior Vice President of Sales & Operations for Canada